Advertisement Pharmaceutical Business review - Page 685 of 5279 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 30, 2026

Zymeworks agrees to buy Theravance Biopharma for $929m

Canadian biotechnology company Zymeworks has signed an agreement to acquire Theravance Biopharma in a cash transaction valued at approximately $929m (C$1.32bn).

Continue
Zymeworks will be entitled to 20% of the proceeds from ampreloxetine. Credit: JHVEPhoto/Shutterstock.com.
June 30, 2026

Anixa Biosciences secures Korean patent for breast cancer vaccine

The vaccine targets human α-lactalbumin, a protein associated with lactation that is abnormally expressed in certain types of breast cancer. Credit: NMK-Studio/Shutterstock.com.
June 29, 2026

FDA issues complete response letter to Sobi’s NASP for gout

Sobi intends to request a meeting with the FDA to discuss the feedback, consider the necessary steps for resubmission and work closely with CMOs to address the outlined deficiencies. Credit: Tapati Rinchumrus/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe
  2. Immunai and Boehringer partner to identify T-cell targets
  3. Ionis grants Recordati rights to zilganersen for Alexander disease
  4. MSD’s Keytruda-Padcev combo secures EC approval for MIBC
  5. RQ Bio secures $115m to develop influenza antibody programme

PRESS RELEASES

Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Honoured With Tswett-Nernst European Award
Dr Imre Molnár Honoured With Tswett-Nernst European Award
DryLab® Automation Extended to Agilent OpenLab CDS System
DryLab® Automation Extended to Agilent OpenLab CDS System

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography